Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ORAI1 | Q96D31 | 3/20 | 0.37 |
| ▸ | ORAI2 | Q96SN7 | 3/20 | 0.37 |
| ▸ | ORAI3 | Q9BRQ5 | 3/20 | 0.37 |
| ▸ | TRPV6 | Q9H1D0 | 3/20 | 0.37 |
| ▸ | PCSK9 | Q8NBP7 | 2/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | CA6 | P23280 | 1/20 | 0.37 |
| ▸ | CA5A | P35218 | 1/20 | 0.37 |
| ▸ | CA7 | P43166 | 1/20 | 0.37 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1808634 | 0.80 | KDM4E (0.35) | LMNASMN1; SMN2 | |
| SCHEMBL5952291 | 0.76 | CA4 (0.32) | ORAI1ORAI2ORAI3TRPV6PCSK9 | |
| SCHEMBL841741 | 0.73 | ESR2 (0.32) | SMN1; SMN2 | |
| Phenylboronic Acid SCHEMBL28466255 | 0.72 | ENPP2 (0.54) | ORAI1ORAI2ORAI3TRPV6PCSK9 | |
| SCHEMBL10797953 | 0.71 | TDP1 (0.37) | ORAI1ORAI2ORAI3TRPV6PCSK9 | |
| SCHEMBL15570627 | 0.70 | TRPV6 (0.44) | ORAI1ORAI2ORAI3TRPV6PCSK9 | |
| SCHEMBL1226528 | 0.70 | TRPV6 (0.44) | ORAI1ORAI2ORAI3TRPV6PCSK9 | |
| SCHEMBL28423595 | 0.69 | ENPP2 (0.39) | ORAI1ORAI2ORAI3TRPV6PCSK9 | |
| SCHEMBL2569853 | 0.68 | ALDH1A1 (0.45) | TDP1TRPA1LMNAALDH1A1RECQL | |
| Benzene SCHEMBL10445518 | 0.68 | ALDH1A1 (0.45) | ORAI1ORAI2ORAI3TRPV6PCSK9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180269528-A1 | ELECTROLYTE FOR LTO TYPE LITHIUM ION BATTERIES | SHENZHEN CAPCHEM TECHNOLOGY CO., LTD (CN) | 2018-09-20 | — | — | US | claimed |
| US-20170317385-A1 | Electrolyte Compositions For Rechargeable Lithium Ion Batteries | BASF CORPORATION (US) | 2017-11-02 | — | — | US | claimed |
| EP-2499181-B1 | POLYMER FOR OPTOELECTRONIC DEVICE | BOE TECHNOLOGY GROUP CO LTD (CN) | 2020-05-13 | — | — | EP | disclosed |
| US-20180269528-A1 | ELECTROLYTE FOR LTO TYPE LITHIUM ION BATTERIES | SHENZHEN CAPCHEM TECHNOLOGY CO., LTD (CN) | 2018-09-20 | — | — | US | disclosed |
| US-20170317385-A1 | Electrolyte Compositions For Rechargeable Lithium Ion Batteries | BASF CORPORATION (US) | 2017-11-02 | — | — | US | disclosed |
| US-20150315127-A1 | THERAPEUTIC COMPOUNDS | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. | 2015-11-05 | — | — | US | disclosed |
| US-8512879-B2 | Polymer for optoelectronic device | GENERAL ELECTRIC COMPANY (US) | 2013-08-20 | — | — | US | disclosed |
| EP-2499181-A1 | POLYMER FOR OPTOELECTRONIC DEVICE | General Electric Company (US) | 2012-09-19 | — | — | EP | disclosed |
| WO-2011059553-A1 | POLYMER FOR OPTOELECTRONIC DEVICE | GENERAL ELECTRIC COMPANY (US) | 2011-05-19 | — | — | WO | disclosed |
| US-20110108807-A1 | POLYMER FOR OPTOELECTRONIC DEVICE | GENERAL ELECTRIC COMPANY (US) | 2011-05-12 | — | — | US | disclosed |
| WO-2011041025-A1 | POLYMER AND OPTOELECTRONIC DEVICE COMPRISING THE SAME | GENERAL ELECTRIC COMPANY (US) | 2011-04-07 | — | — | WO | disclosed |
| US-20110077373-A1 | POLYMER AND OPTOELECTRONIC DEVICE COMPRISING THE SAME | GENERAL ELECTRIC COMPANY (US) | 2011-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150315127-A1 | THERAPEUTIC COMPOUNDS | HTR2C, GRK2, GRK3 | ORAI1 2016/4885ORAI2 1465/4885ORAI3 1657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.